During the past decade, NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center conducted 232 clinical trials. In the 10-year time frame, 232 clinical trials started and 169 clinical trials were completed, i.e. on average, 72.8% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 98 clinical trials were completed. i.e. 111.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 154 trials, followed by "Children's Oncology Group" with 150 trials sponsored, "SWOG Cancer Research Network" with 99 trials sponsored, "Radiation Therapy Oncology Group" with 38 trials sponsored and "Alliance for Clinical Trials in Oncology" with 38 trials sponsored. Other sponsors include 164 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 399 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "SWOG Cancer Research Network" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "Children's Oncology Group" with 10 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" are "Leukemia" (49 trials), "Lymphoma" (38 trials), "Breast Cancer" (36 trials), "Sarcoma" (35 trials) and "Recurrent Malignant Solid Neoplasm" (31 trials). Many other conditions were trialed in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" are "Drug" (507 trials), "Other" (234 trials), "Biological" (186 trials), "Procedure" (173 trials) and "Radiation" (153 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (135 trials), "radiation therapy" (74 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (57 trials) and "cyclophosphamide" (54 trials). Other intervention names were less common.

The vast majority of trials in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center" are 543 trials for "All" genders, 80 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center". undefined are not yet recruiting, 94 are recruiting, 154 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 320 completed trials in NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, 5 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, 113 "Phase 1" clinical trials were conducted, 319 "Phase 2" clinical trials and 196 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 23 trials that are defined as “Not Applicable".